US$ 28.87
obesity treatment with bariatric surgery vs glp-1 receptor agonists GLP1 (2025): Bariatric Surgery vs Receptor Agonists, ., ⛔️Disclaimer: This post is for educational and informational purposes only Metabolic and bariatric surgery versus
Description
Nat Med (2022) 28:5918

In rats, feeding activity and food intake decreased following intracerebroventricular injection of GLP-1, an effect counteracted by co-administration of a GLP-1 receptor antagonist (71, 72), suggesting central GLP-1 as a potent inhibitor of feeding

Which GLP-1 option is best for weight loss
Long-acting agents seem to have a lower incidence of gastrointestinal adverse effects (166), likely due to tachyphylaxis in gastric emptying with sustained GLP-1R stimulation

doi: 10.1016/S0021-9258(18)68261-4 141 GkeRLarsenPJMikkelsenJDSheikhSP

Are you stable right now, or still titrating